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Vaccination for Escherichia coli O157:H7 in
Market Ready Feedlot Cattle
mine the ecology of E. coli O157:H7
in Nebraska beef feedlots. Most
recently, research has focused on
identifying and scientifically test-
ing easily implemented on-farm
intervention strategies to control the
carriage and shedding of E. coli
O157:H7 in feces of feedlot cattle.
Previous research at Nebraska
(Potter et al., Vaccine 2004) found
that vaccinating feedlot cattle
against Type III secretory proteins
of Escherichia coli O157:H7 reduced
the probability of fecal shedding of
the organism by 59%. In that study
cattle were vaccinated three times
at three-week intervals. Current
feedlot practices make a three-
vaccination treatment protocol
challenging to implement. How-
ever, vaccinating cattle once at
reimplant, or twice, once at initial
processing and again at reimplant,
would be much easier to implement
into current feedlot practices. There-
fore, an experiment was conducted
to evaluate the effects of varying the
number of doses of a commercially
prepared vaccine on the probability
that cattle shed E. coli O157:H7 in
feces.
Procedure
The clinical trial was conducted
during summer (May - September)
of 2003 at the University of
Nebraska Beef Research Feedlot at
Ithaca, Nebraska. Four-hundred-
eighty medium-weight steers were
stratified by weight and assigned
randomly to 60 pens (8 head/pen)
and to one of four vaccination
treatments (2 head/treatment)
within a pen. Steers were blocked
into four groups based on replica-
tion of dietary treatment. Dietary
treatments are summarized in a
separate report (2005 Nebraska
Beef Report, pp. 28-30). Vaccine
(2 ml/dose) was administered sub-
cutaneously in the neck using an
18 ga x 5/8-inch needle. Vaccina-
tion treatments included: 1) no vac-
cination; 2) vaccinated once at
re-implant (day 42); 3) vaccinated
upon arrival (day 0) and again at
re-implant (day 42); and 4) vacci-
nated on arrival (day 0), at day 21,
and again at re-implant (day 42).
An additional 128 steers were
assigned to 12 pens and two study
blocks within the same feedlot to
serve as unvaccinated external con-
trols. Blocking criteria for external
controls was steers per pen (8 head
in 8 pens; 16 head in 4 pens). Steers
were fed for an average of 138 days
and each steer was sampled by rec-
tal fecal grab every three weeks of
the feeding period, resulting in one
pre-treatment period (day 0), two
interim periods (day 21, day 42),
and four test-period samplings
(days 63, 84, 105, and 126). Feces
from these cattle were collected for
culture in two sample blocks within
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Summary
A clinical trial was conducted in
summer 2003 to evaluate effects of vac-
cinating feedlot cattle against Type III
secretory proteins of enterohemor-
rhagic Escherichia coli on prevalence
of E. coli O157:H7 in feces. Treat-
ments included: 1) no vaccination;
2) vaccinated once at re-implant (day
42); 3) vaccinated upon arrival (day 0)
and again at re-implant (day 42); and
4) vaccinated on arrival (day 0), at
day 21, and again at re-implant (day
42). Vaccination effectively reduced
the proportion of feedlot cattle shed-
ding O157 in the feces, the effect was
dose-responsive, and vaccination
within a pen conferred protection to
unvaccinated pen-mates (herd-
immunity).
Introduction
Escherichia coli O157:H7 has been
a pathogen of concern to the beef
industry for two decades. Because
cattle represent a significant reser-
voir of E. coli O157:H7, a great deal
of research has been conducted at
the University of Nebraska to deter-
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the same test period on consecutive
days for vaccinated and external
control pens.
All fecal samples were taken
immediately to the UNL E. coli lab
and analyzed for presence of E. coli
O157:H7 using procedures previ-
ously described (2004 Nebraska Beef
Report, pp. 67-68) with modifica-
tions.
The odds of a treated animal
shedding E. coli O157:H7 was com-
pared to that of unvaccinated con-
trol cattle within the pen and
control cattle in the external pens,
accounting for repeated measures,
block, and pen using the GENMOD
procedure of SAS. Adjusted odds
ratios (OR) were converted to rela-
tive risk (RR) using marginal prob-
abilities for prevalence and
vaccination. Vaccine efficacy was
calculated as (1-RR). Feedlot perfor-
mance was evaluated using the
MIXED procedure of SAS account-
ing for block and pen. Because
treatments were assigned to ani-
mals within a pen, only weights
and average daily gain (ADG) can
be reported for the direct effect of
vaccination treatment.
Results
E. coli Results
In total, E. coli O157:H7 was
recovered from 845 of 4253 culture
observations (20%) from cattle in
treated and external control pens.
During the pre-treatment sampling
period, the proportion of cattle
shedding E. coli O157:H7 within
the 60 treated pens was 45% and
was not different (P > 0.10) for ani-
mals allocated to different vaccine
treatments. The proportion of cattle
shedding E. coli O157:H7 among
the external control pens was 30.5%
during the same test period and
was significantly lower (P < 0.05)
than treated pens; however, the pro-
portion of cattle shedding E. coli
O157:H7 among the external con-
trol pens was higher (P < 0.05) than
treated pens throughout the
remainder of the study (Figure 1).
Table 1. Finishing performance and carcass merit for steers receiving 0,1, 2, or 3 doses
of vaccine within vaccinated pens.
Treatmenta
Item 0 1 2 3 SEMa VACb
Steers 120 120 120 120
Initial BW, lb 745 742 742 745 2.32 0.59
Final BW, lbc 1242 1233 1229 1244 6.26 0.27
ADG, lb 3.60 3.56 3.53 3.62 0.41 0.45
HCW, lb 782 777 774 784 3.94 0.27
12th rib fat, in. 0.37 0.32 0.36 0.34 0.04 0.67
Marbling d 489 503 485 487 5.51 0.09
aStandard error of the mean
bMain effect of vaccination treatment.
cCalculated from carcass weight, adjusted to a 63% common dressing percentage.
dMarbling = Marbling score = 400 = Slight0, 450 = Slight50, 500 = Small0, etc.
Figure 2. Percentage reduction in E. coli O157:H7 shedding (vaccine efficacy) by
steers receiving 1, 2, or 3 doses of vaccine within treated pens compared to
pens receiving no vaccine (21-84 days post treatment).
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Figure 1. The proportion of steers shedding E. coli O157:H7 by test period and
treatment (0, 1, 2, or 3 doses of vaccine) within treated pens compared to
untreated pens.
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The proportion of cattle shedding
E. coli O157:H7 in both treated and
control pens during test periods
four to seven differed significantly
by test period (P < 0.05, Figure 1).
There was no interaction between
vaccination and test periods four to
seven. During test periods four to
seven cattle in pens receiving one,
two, or three doses of vaccine were
less likely to shed E. coli O157:H7
than cattle in pens not receiving
vaccine (OR=0.33; P=0.0008) — a
vaccine efficacy of 59%. Vaccine
efficacy of receiving one, two, or
three doses of vaccine was 52%,
58%, and 68%, respectively
(P < 0.01 for each, Figure 2), com-
pared with cattle in pens not receiv-
ing vaccine. Unvaccinated cattle in
pens receiving vaccine treatments
were also less likely to shed E. coli
O157:H7 than cattle in pens not
receiving vaccine (OR=0.42,
P=0.02). Compared to unvaccinated
cattle within the pens receiving
vaccine treatments, the odds of
shedding E. coli O157:H7 decreased
as cattle received one, two, or three
doses of vaccine (OR=0.94, 0.82,
and 0.59 respectively). Cattle receiv-
ing three doses of vaccine were 35%
less likely to shed E. coli O157:H7
than unvaccinated cattle in the
same pen (P=0.06) during the post-
treatment period.
Finishing Performance
Least squares means for finish-
ing performance measures are pre-
sented in Table 1. There were no
differences (P > 0.10) in finishing
performance for steers receiving
one, two, or three doses of vaccine
compared with unvaccinated steers
within the same pen. These data
suggest vaccinating feedlot cattle
against Type III secretory proteins
of enterohemorrhagic Escherichia
coli will have no measurable impact
on finishing performance.
In conclusion vaccine efficacy
improved with the number of doses
administered, and vaccinating a
majority of cattle within a pen
offered a significant protective effect
(herd immunity) to non-vaccinated
cattle within the same pen. Further-
more, vaccinating feedlot cattle
against Type III secretory proteins
of enterohemorrhagic Escherichia
coli had no detrimental effects on
finishing performance. Vaccination
appears to be a promising pre-
harvest intervention strategy for the
control of E. coli O157:H7.
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